Search

everythinglearnresearchcommunity

for

Search:↓

Capivasertib improves survival in certain breast cancer cases but requires careful management of side effects.

A KLK5 inhibitor effectively improved skin symptoms in a mouse model of Netherton Syndrome.

BI 2536 had limited effectiveness against several advanced cancers and caused significant side effects.

Combining hair transplantation with PRP is more effective for treating hair loss than hair transplantation alone.

Ritlecitinib may be more effective for severe alopecia areata than conventional treatments.

The treatment showed high response rates and was well-tolerated, potentially extending patient survival.

Ritlecitinib effectively treats alopecia areata and is safe for long-term use in people 12 and older.

Ritlecitinib helps regrow hair in people with alopecia totalis and universalis and is safe to use.

JAK inhibitors can be safely used in alopecia areata patients with latent hepatitis B or tuberculosis, with proper monitoring.

CT-707 is effective and safe for treating certain Chinese lung cancer patients.

JAK inhibitors can be safely used for alopecia areata in patients with latent hepatitis B or stable tuberculosis with proper monitoring.

BKN-1 antibody targets specific keratin in basal cell epithelioma and normal skin basal cells.

VDC-1101 shows potential as a treatment for canine cutaneous T-cell lymphoma.

Careful monitoring is crucial to prevent JC virus reactivation in lupus patients treated with rituximab.

Immunomodulatory therapies are effective for treating cutaneous lymphoma, particularly in early stages.

Anti-CD19 therapy may help treat SLE and NMOSD.

The combination of mitoxantrone, etoposide, and prednisolone is effective for treating relapsed lymphoma with manageable side effects.

Uveal melanoma is hard to treat when it spreads, but a new drug, tebentafusp, helps patients live longer.

MC-DNA vector-based gene therapy can temporarily treat CBS deficiency in mice.

Amotosalen-treated donor T-cells can prevent late CMV infection after bone marrow transplants.

Ritlecitinib effectively reduces hair loss in JAK inhibitor-naïve alopecia areata patients.

Sintilimab with chemotherapy improves survival and response in advanced lung cancer but increases some side effects.

Belimumab effectively controls SLE disease activity and reduces steroid use.

Ritlecitinib shows promise as a versatile treatment for various autoimmune and inflammatory diseases.

Pemigatinib may be effective for treating ZMYM2::FGFR1 fusion-positive leukemia.

MVP treatment is effective and safe for recurrent breast cancer.

Mycophenolate mofetil is safer and more effective than cyclophosphamide for treating lupus nephritis.

Ritlecitinib is generally safe for long-term use, with mostly mild side effects.

MK-5108 is safe and shows potential against tumors, especially alone.

Kanglaite injection with chemotherapy improves treatment and reduces side effects for advanced lung cancer.